We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 11 AUGUST 2015
Lumigan Patents Upheld By Unexpected Results
Foley & Lardner LLP
In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating to Lumigan® 0.01% glaucoma eye drops.
United StatesIntellectual Property






